Integrated Whole Genome Sequencing Approach Resolving Diagnostic Challenges in Pediatric Huntington Disease
Main Article Content
Abstract
Pediatric patients with progressive neurological symptoms often face prolonged diagnostic journeys as clinical presentations overlap with multiple conditions or occur without informative family history. Traditional diagnostic approaches including chromosomal microarray, targeted gene panels, and whole exome sequencing have limitations that can delay or prevent accurate diagnosis. Whole genome sequencing provides comprehensive genomic coverage without gene preselection. However, short-read technologies struggle to characterize complex genomic features such as large repeat expansions. This study presents four pediatric cases of Huntington disease diagnosed through an integrated sequencing approach combining short-read and long-read whole genome sequencing technologies. Patients ranged from 10 to 12 years of age and presented with diverse symptoms including autism, intellectual disability, developmental regression, seizures, and movement abnormalities. Two patients had no family history suggestive of Huntington disease. The integrated approach enabled diagnosis when clinical presentations provided insufficient guidance for targeted testing, eliminated delays from sequential testing strategies, and provided clinically meaningful quantification of CAG repeat expansions. In three of four cases, long-read sequencing revealed discrepancies of 19 to 32 repeats compared to short-read predictions, fundamentally altering clinical interpretation and prognosis. These cases demonstrate how comprehensive genomic evaluation addresses diagnostic challenges in childhood-onset genetic disorders with nonspecific presentations.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Bagger FO, Borgwardt L, Jespersen AS, et al. Whole genome sequencing in clinical practice. BMC Medical Genomics 2024 17:1. 2024;17(1):1-16. doi:10.1186/S12920-024-01795-W
3. Chaisson MJP, Sanders AD, Zhao X, et al. Multi-platform discovery of haplotype-resolved structural variation in human genomes. Nat Commun. 2019;10(1):1784. doi:10.1038/S41467-018-08148-Z
4. Jain M, Koren S, Miga KH, et al. Nanopore sequencing and assembly of a human genome with ultra-long reads. Nat Biotechnol. 2018;36(4):338-345. doi:10.1038/NBT.4060,
5. Willemsen R, Levenga J, Oostra B. CGG repeat in the FMR1 gene: Size matters. Clin Genet. 2011;80(3):214-225. doi:10.1111/J.1399-0004.2011.01723.X,
6. Campuzano V, Montermini L, Moltò MD, et al. Friedreich’s ataxia: Autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science (1979). 1996;271(5254):1423-1427. doi:10.1126/SCIENCE.271.5254.1423,
7. David G, Abbas N, Stevanin G, et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet. 1997;17(1):65-70. doi:10.1038/NG0997-65,
8. MacDonald ME, Ambrose CM, Duyao MP, et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell. 1993;72(6):971-983. doi:10.1016/0092-8674(93)90585-E
9. Andrew SE, Goldberg YP, Kremer B, et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington’s disease. Nat Genet. 1993;4(4):398-403. doi:10.1038/NG0893-398
10. Powis Z, Lutz J, Liaquat K, Querubin JA, Batish SD. Expanding the Phenotype of Extremely Early Onset Juvenile Huntington’s Disease: A Case Report and Review of Previously Published Cases. Am J Med Genet A. Published online 2024:e63894. doi:10.1002/AJMG.A.63894
11. Cronin T, Rosser A, Massey T. Clinical Presentation and Features of Juvenile-Onset Huntington’s Disease: A Systematic Review. J Huntingtons Dis. 2019;8(2):171-179. doi:10.3233/JHD-180339
12. Oosterloo M, Touze A, Byrne LM, et al. Clinical Review of Juvenile Huntington’s Disease. J Huntingtons Dis. 2024;13(2):149. doi:10.3233/JHD-231523
13. Nance M. The Juvenile HD Handbook A Guide for Families and Caregivers-SECOND EDITION. 2007.
14. Ross LF, Saal HM, David KL, Anderson RR. Technical report: Ethical and policy issues in genetic testing and screening of children. Genetics in Medicine. 2013;15(3):234-245. doi:10.1038/gim.2012.176
15. Neerman N, Faust G, Meeks N, et al. A clinically validated whole genome pipeline for structural variant detection and analysis. BMC Genomics. 2019;20(Suppl 8):545. doi:10.1186/S12864-019-5866-Z
16. Dolzhenko E, Deshpande V, Schlesinger F, et al. ExpansionHunter: a sequence-graph-based tool to analyze variation in short tandem repeat regions. Bioinformatics. 2019;35(22):4754-4756. doi:10.1093/bioinformatics/btz431
17. Stevanovski I, Chintalaphani SR, Gamaarachchi H, et al. Comprehensive genetic diagnosis of tandem repeat expansion disorders with programmable targeted nanopore sequencing. Sci Adv. 2022;8(9):17. doi:10.1126/SCIADV.ABM5386
18. Kaplun L, Krautz-Peterson G, Neerman N, et al. ONT long-read WGS for variant discovery and orthogonal confirmation of short read WGS derived genetic variants in clinical genetic testing. Front Genet. 2023;14:1145285. doi:10.3389/FGENE.2023.1145285/FULL
19. Kaplun L, Krautz-Peterson G, Neerman N, et al. ONT in Clinical Diagnostics of Repeat Expansion Disorders: Detection and Reporting Challenges. Int J Mol Sci. 2025;26(6):2725. doi:10.3390/IJMS26062725
20. Halman A, Dolzhenko E, Oshlack A. STRipy: A graphical application for enhanced genotyping of pathogenic short tandem repeats in sequencing data. Hum Mutat. 2022;43(7):859-868. doi:10.1002/HUMU.24382
21. Hiatt L, Weisburd B, Dolzhenko E, et al. STRchive: a dynamic resource detailing population-level and locus-specific insights at tandem repeat disease loci. medRxiv. Published online May 21, 2024. doi:10.1101/2024.05.21.24307682
22. Mantuano E, Romano S, Veneziano L, et al. Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2. J Neurol Sci. 2010;291(1-2):30-36. doi:10.1016/J.JNS.2010.01.010
23. Spacey SD, Materek LA, Szczygielski BI, Bird TD. Two novel CACNA1A gene mutations associated with episodic ataxia type 2 and interictal dystonia. Arch Neurol. 2005;62(2):314-316. doi:10.1001/ARCHNEUR.62.2.314
24. Verriello L, Pauletto G, Nilo A, et al. Epilepsy and episodic ataxia type 2: family study and review of the literature. J Neurol. 2021;268(11):4296-4302. doi:10.1007/S00415-021-10555-0
25. Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell. 1996;87(3):543-552. doi:10.1016/S0092-8674(00)81373-2
26. Schultz JL, Langbehn DR, Al-Kaylani HM, et al. Longitudinal Clinical and Biological Characteristics in Juvenile-Onset Huntington’s Disease. Mov Disord. 2022;38(1):113. doi:10.1002/MDS.29251
27. Handsaker RE, Kashin S, Reed NM, et al. Long somatic DNA-repeat expansion drives neurodegeneration in Huntington’s disease. Cell. 2025;188(3):623-639.e19. doi:10.1016/J.CELL.2024.11.038
28. McLean ZL, Gao D, Correia K, et al. Splice modulators target PMS1 to reduce somatic expansion of the Huntington’s disease-associated CAG repeat. Nat Commun. 2024;15(1). doi:10.1038/S41467-024-47485-0
29. Bunting EL, Donaldson J, Cumming SA, et al. Antisense oligonucleotide–mediated MSH3 suppression reduces somatic CAG repeat expansion in Huntington’s disease iPSC–derived striatal neurons. Sci Transl Med. 2025;17(785). doi:10.1126/SCITRANSLMED.ADN4600,
30. Runheim H, Pettersson M, Hammarsjö A, et al. The cost-effectiveness of whole genome sequencing in neurodevelopmental disorders. Sci Rep. 2023;13(1):6904. doi:10.1038/S41598-023-33787-8
31. Nurchis MC, Radio FC, Salmasi L, et al. Cost-Effectiveness of Whole-Genome vs Whole-Exome Sequencing Among Children With Suspected Genetic Disorders. JAMA Netw Open. 2024;7(1):e2353514. doi:10.1001/JAMANETWORKOPEN.2023.53514